123 related articles for article (PubMed ID: 37659340)
1. The association between hospital variation in curative treatment for esophagogastric cancer and health-related quality of life and survival.
Vissers PAJ; Luijten JCHBM; Lemmens VEPP; van Laarhoven HWM; Slingerland M; Wijnhoven BPL; Rosman C; Mook S; Heisterkamp J; Hendriksen EM; Gisbertz SS; Nieuwenhuijzen GAP; Verhoeven RHA
Eur J Surg Oncol; 2023 Oct; 49(10):107019. PubMed ID: 37659340
[TBL] [Abstract][Full Text] [Related]
2. [Hospital of diagnosis influences the probability of receiving curative treatment for oesophageal and gastric cancer].
van Putten M; Verhoeven RHA; Koëter M; van Laarhoven HWM; van Sandick JW; Plukker JTM; Siersema PD; Hulshof MCCM; Wijnhoven BPL; Lemmens VEPP; Nieuwenhuijzen GAP
Ned Tijdschr Geneeskd; 2018; 162():D1970. PubMed ID: 29600921
[TBL] [Abstract][Full Text] [Related]
3. Changes in hospital variation in the probability of receiving treatment with curative intent for esophageal and gastric cancer.
Luijten JCHBM; Vissers PAJ; Lingsma H; van Leeuwen N; Rozema T; Siersema PD; Rosman C; van Laarhoven HWM; Lemmens VEP; Nieuwenhuijzen GAP; Verhoeven RHA
Cancer Epidemiol; 2021 Apr; 71(Pt A):101897. PubMed ID: 33484974
[TBL] [Abstract][Full Text] [Related]
4. Hospital of Diagnosis Influences the Probability of Receiving Curative Treatment for Esophageal Cancer.
van Putten M; Koëter M; van Laarhoven HWM; Lemmens VEPP; Siersema PD; Hulshof MCCM; Verhoeven RHA; Nieuwenhuijzen GAP
Ann Surg; 2018 Feb; 267(2):303-310. PubMed ID: 27811508
[TBL] [Abstract][Full Text] [Related]
5. Hospital of diagnosis and probability of having surgical treatment for resectable gastric cancer.
van Putten M; Verhoeven RH; van Sandick JW; Plukker JT; Lemmens VE; Wijnhoven BP; Nieuwenhuijzen GA
Br J Surg; 2016 Feb; 103(3):233-41. PubMed ID: 26621158
[TBL] [Abstract][Full Text] [Related]
6. Baseline Health-related Quality of Life Predicts Bladder Cancer-specific Survival Following Radical Cystectomy.
Westhofen T; Eismann L; Buchner A; Schlenker B; Giessen-Jung C; Becker A; Stief CG; Kretschmer A
Eur Urol Focus; 2022 Nov; 8(6):1659-1665. PubMed ID: 35184991
[TBL] [Abstract][Full Text] [Related]
7. Presentation, Treatment, and Prognosis of Esophageal Carcinoma in a Nationwide Comparison of Sweden and the Netherlands.
Kalff MC; Gottlieb-Vedi E; Verhoeven RHA; van Laarhoven HWM; Lagergren J; Gisbertz SS; Markar SR; van Berge Henegouwen MI
Ann Surg; 2021 Nov; 274(5):743-750. PubMed ID: 34353984
[TBL] [Abstract][Full Text] [Related]
8. Health-related quality of life one year after the diagnosis of oesophageal cancer: a population-based study from the Swedish National Registry for Oesophageal and Gastric Cancer.
Sunde B; Lindblad M; Malmström M; Hedberg J; Lagergren P; Nilsson M
BMC Cancer; 2021 Nov; 21(1):1277. PubMed ID: 34836512
[TBL] [Abstract][Full Text] [Related]
9. Follow-up strategies for patients treated for non-metastatic colorectal cancer.
Jeffery M; Hickey BE; Hider PN
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD002200. PubMed ID: 31483854
[TBL] [Abstract][Full Text] [Related]
10. Clinical variation in the organization of clinical pathways in esophagogastric cancer, a mixed method multiple case study.
Luijten JCHBM; Vissers PAJ; Brom L; de Bièvre M; Buijsen J; Rozema T; Mohammad NH; van Duijvendijk P; Kouwenhoven EA; Eshuis WJ; Rosman C; Siersema PD; van Laarhoven HWM; Verhoeven RHA; Nieuwenhuijzen GAP; Westerman MJ
BMC Health Serv Res; 2022 Apr; 22(1):527. PubMed ID: 35449018
[TBL] [Abstract][Full Text] [Related]
11. Health-related quality of life in curatively-treated patients with esophageal or gastric cancer: A systematic review and meta-analysis.
van den Boorn HG; Stroes CI; Zwinderman AH; Eshuis WJ; Hulshof MCCM; van Etten-Jamaludin FS; Sprangers MAG; van Laarhoven HWM
Crit Rev Oncol Hematol; 2020 Oct; 154():103069. PubMed ID: 32818901
[TBL] [Abstract][Full Text] [Related]
12. Recurrence after preoperative chemotherapy and surgery for gastric adenocarcinoma: a multicenter study.
Mokadem I; Dijksterhuis WPM; van Putten M; Heuthorst L; de Vos-Geelen JM; Haj Mohammad N; Nieuwenhuijzen GAP; van Laarhoven HWM; Verhoeven RHA
Gastric Cancer; 2019 Nov; 22(6):1263-1273. PubMed ID: 30949777
[TBL] [Abstract][Full Text] [Related]
13. Prognosis and Treatment After Diagnosis of Recurrent Esophageal Carcinoma Following Esophagectomy with Curative Intent.
Parry K; Visser E; van Rossum PS; Mohammad NH; Ruurda JP; van Hillegersberg R
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1292-300. PubMed ID: 26334295
[TBL] [Abstract][Full Text] [Related]
14. Hospital of diagnosis and probability to receive a curative treatment for oesophageal cancer.
Koëter M; van Steenbergen LN; Lemmens VE; Rutten HJ; Roukema JA; Wijnhoven BP; Nieuwenhuijzen GA
Eur J Surg Oncol; 2014 Oct; 40(10):1338-45. PubMed ID: 24484779
[TBL] [Abstract][Full Text] [Related]
15. Axillary treatment for operable primary breast cancer.
Bromham N; Schmidt-Hansen M; Astin M; Hasler E; Reed MW
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004561. PubMed ID: 28052186
[TBL] [Abstract][Full Text] [Related]
16. Short-term outcomes of health-related quality of life in patients with locally recurrent rectal cancer: multicentre, international, cross-sectional cohort study.
Harji DP; McKigney N; Koh C; Solomon MJ; Griffiths B; Evans M; Heriot A; Sagar PM; Velikova G; Brown JM
BJS Open; 2023 Jan; 7(1):. PubMed ID: 36787174
[TBL] [Abstract][Full Text] [Related]
17. Definitive chemoradiation or surgery in elderly patients with potentially curable esophageal cancer in the Netherlands: a nationwide population-based study on patterns of care and survival.
Koëter M; van Putten M; Verhoeven RHA; Lemmens VEPP; Nieuwenhuijzen GAP
Acta Oncol; 2018 Sep; 57(9):1192-1200. PubMed ID: 29528262
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy for advanced gastric cancer.
Wagner AD; Syn NL; Moehler M; Grothe W; Yong WP; Tai BC; Ho J; Unverzagt S
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD004064. PubMed ID: 28850174
[TBL] [Abstract][Full Text] [Related]
19. Treatment decision-making during outpatient clinic visit of patients with esophagogastric cancer. The perspectives of clinicians and patients, a mixed method, multiple case study.
Luijten JCHBM; Brom L; Vissers PAJ; van de Wouw YAJ; Warmerdam FARM; Heisterkamp J; Mook S; Oulad Hadj J; van Det MJ; Timmermans L; Hulshof MCCM; van Laarhoven HWM; Rosman C; Siersema PD; Westerman MJ; Verhoeven RHA; Nieuwenhuijzen GAP
Cancer Med; 2022 Jun; 11(12):2427-2444. PubMed ID: 35166037
[TBL] [Abstract][Full Text] [Related]
20. A randomised controlled trial to assess the cost-effectiveness of intensive versus no scheduled follow-up in patients who have undergone resection for colorectal cancer with curative intent.
Mant D; Gray A; Pugh S; Campbell H; George S; Fuller A; Shinkins B; Corkhill A; Mellor J; Dixon E; Little L; Perera-Salazar R; Primrose J
Health Technol Assess; 2017 May; 21(32):1-86. PubMed ID: 28641703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
